Wow. Talk about timing.
I just posted a few weeks ago about my dread of renewing my EpiPen prescription because of its cost—over $700 without insurance, and still over $600 with my insurance!
It seems other healthcare advocates, the media, Congress and even the presidential nominees are at last realizing how insane it is to charge that much for literally a few cents worth of epinephrine.
EpiPens are not even new to the market, like so many other high-priced drugs. It’s been around for a long time, so Mylan pharmaceuticals can’t claim it’s trying to recoup R&D costs. In fact, … Continue reading
Prevnar 13: As seen on TV
I was watching TV the other evening and, as usual, was forced to sit through multiple back-to-back prescription drug commercials.
One that caught my attention was for Prevnar 13, which is one of the pneumonia vaccines. (13 because it protects against 13 strains of streptococcus pneumonia.)
The commercial stated Prevnar 13 was for adults aged 50 and older.
That statement’s true, but needs some clarification.
Yes, Pfizer did get FDA approval a few years ago to market Prevnar 13 to adults over the age of 50. Previously, the vaccine was only used for … Continue reading
Healthcare Not Fair is a satirical YouTube video series created by a real-life physician, Dr. Waqas Khan, to highlight problems within our broken healthcare system.
Their latest video takes a stab at electronic health records, EHR—or, as they call it, Electronic Hell Records!
Other videos by Healthcare Not Fair:
I just saw my primary care physician a few weeks ago, and I can relate to the fictional patient’s experience in the video. Receptionists really do keep their eyes glued to their computer screens!
My physician isn’t that bad, … Continue reading
Many years ago I had a primary care doctor who used to perform a total body skin examination (TBSE) on me every year as part of my annual exam.
Of course, those all-inclusive physicals are a thing of the past. I haven’t had a physician perform a TBSE for a long time.
I often wondered about that. A TBSE seems like a relatively easy and harmless way to quickly screen for skin cancer. The goal, of course, is to find a melanoma, the deadly skin cancer, when it’s small and possibly curable.
But the go-to source for screening … Continue reading
They say a picture is worth a thousand words, and the online news site Vox recently sought to open Americans’ eyes as to how much more we pay for healthcare compared to other countries.
America’s healthcare prices are out of control. These 11 charts prove it.
I can’t copy their charts, but basically they are bar graphs. The bar that shows how much patients in the US pay for similar drugs and services towers over the others like a skyscraper over a neighborhood of single-family homes. Like this:
Vox got its information from the International Federation of Health Plans (IFHP)… Continue reading
Up, up and away!
Does anyone’s income go up as fast as their health insurance premium? I wish.
11.6%. That’s how much more my current health insurance provider wants to charge for my bronze high-deductible health plan in 2017.
And although 11.6% seems like a lot to me, another company in my state is requesting a 19.9% average increase on all its plans, with a 28% increase on its gold plan!
So far, the rate increases that have been made public in other states are all pretty high, averaging well into the double digits. So at least I’m not … Continue reading
Knowledge is king
That’s the take home message from Professor (of pharmacy) James McCormack’s latest parody video, End of the Line, which takes a whack at healthcare’s increasingly pervasive and rigid medical guidelines.
If followed to the letter, these guidelines (often based on research funded by drug companies) would have everyone diagnosed with a disease and taking one or more medications. Medical guidelines may be great for the drug business, but not so much for individualized, patient-centric care and shared decision-making.
Chronic disease state guidelines (blood pressure/lipids/glucose/bone density) do not provide clinicians with
… Continue reading
Just yesterday I posted about the United States Preventive Services Task Force (USPSTF) and the fine line they walk between providing evidence-based recommendations for screening tests and making medical specialist groups happy.
Sometimes it just doesn’t happen.
The task force recently gave an “I” grade to vision screening in patients over 65. An I grade, or Insufficient evidence, means that the task force can’t definitively say that the benefits of vision screening in older adults outweigh the possible harms.
The American Academy of Ophthalmology (AAO) doesn’t agree.
Specifically, the task force reviewed the evidence for primary care doctors screening for … Continue reading
Not in my humble opinion.
I just read about this idea proposed by health financing researchers out of MIT and Harvard: Financing health care with consumer loans.
They begin their article with what we all know—health care, specifically prescription drugs in this case, costs too much.
We propose a practical way to increase drug affordability through health care loans (HCLs)—the equivalent of mortgages for large health care expenses. HCLs allow patients in both multipayer and single-payer markets to access a broader set of therapeutics, including expensive short-duration treatments that are curative.
When they talk about “curative” drug treatments, they … Continue reading
Last November, with much media coverage, several members of Congress announced the formation of The Affordable Drug Pricing Task Force, promising to “take action to combat the skyrocketing costs of pharmaceuticals.”
Finally! I thought.
Related post: Prices continue to increase for generics
But I haven’t heard much since then.
There was a little noise earlier this month when the House Oversight Committee (of which the task force is a subcommittee, I believe) attempted to grill the now infamous Martin Shkreli about why he thought it was okay to jack up the price of Daraprim from $13 a pill to … Continue reading